Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / Common Stock
Shares outstanding
59,119,327
Total 13F shares
42,413,548
Share change
-3,953,431
Total reported value
$538,068,965
Put/Call ratio
52%
Price per share
$12.69
Number of holders
109
Value change
-$35,411,925
Number of buys
61
Number of sells
51

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
GOLDMAN SACHS GROUP INC
13F
Company
7.1%
4,205,392
$39,110,000 31 Mar 2015
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
7%
4,134,157
$38,448,000 31 Mar 2015
13F
PAULSON & CO. INC.
13F
Company
6.7%
3,950,000
$36,735,000 31 Mar 2015
13F
Palo Alto Investors LP
13F
Company
6.4%
3,803,408
$35,372,000 31 Mar 2015
13F
FMR LLC
13F
Company
5%
2,955,429
$27,485,000 31 Mar 2015
13F
STATE STREET CORP
13F
Company
4.5%
2,685,595
$24,974,000 31 Mar 2015
13F
ARMISTICE CAPITAL, LLC
13F
Company
3.9%
2,284,000
$21,241,000 31 Mar 2015
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
3.3%
1,932,189
$17,969,000 31 Mar 2015
13F
BAKER BROS. ADVISORS LP
13F
Company
3%
1,750,230
$16,277,000 31 Mar 2015
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.7%
1,599,162
$14,872,000 31 Mar 2015
13F
BlackRock Fund Advisors
13F
Company
2.5%
1,485,191
$13,812,000 31 Mar 2015
13F
MORGAN STANLEY
13F
Company
2.4%
1,421,114
$13,217,000 31 Mar 2015
13F
GREAT POINT PARTNERS LLC
13F
Company
2.3%
1,388,599
$12,914,000 31 Mar 2015
13F
VANGUARD GROUP INC
13F
Company
2.1%
1,248,686
$11,612,000 31 Mar 2015
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
1.9%
1,111,149
$10,334,000 31 Mar 2015
13F
Invesco Ltd.
13F
Company
1.7%
1,022,178
$9,506,000 31 Mar 2015
13F
Jefferies Group LLC
13F
Company
1.4%
830,402
$7,723,000 31 Mar 2015
13F
MACQUARIE GROUP LTD
13F
Company
1.2%
709,474
$6,598,000 31 Mar 2015
13F
J. Goldman & Co LP
13F
Company
0.99%
584,285
$5,434,000 31 Mar 2015
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.92%
543,390
$5,054,000 31 Mar 2015
13F
NORTHERN TRUST CORP
13F
Company
0.78%
462,602
$4,303,000 31 Mar 2015
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.67%
396,070
$3,683,000 31 Mar 2015
13F
DEUTSCHE BANK AG\
13F
Company
0.65%
382,364
$3,554,000 31 Mar 2015
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.62%
365,628
$3,400,000 31 Mar 2015
13F
D. E. Shaw & Co., Inc.
13F
Company
0.6%
352,781
$3,281,000 31 Mar 2015
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.59%
350,000
$3,255,000 31 Mar 2015
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.38%
224,072
$2,083,000 31 Mar 2015
13F
Bank of New York Mellon Corp
13F
Company
0.37%
220,731
$2,053,000 31 Mar 2015
13F
Alyeska Investment Group, L.P.
13F
Company
0.34%
202,216
$1,881,000 31 Mar 2015
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.34%
201,635
$1,875,000 31 Mar 2015
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.33%
195,100
$1,814,000 31 Mar 2015
13F
ASCEND CAPITAL, LLC
13F
Company
0.28%
168,300
$1,566,000 31 Mar 2015
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.28%
162,892
$1,515,000 31 Mar 2015
13F
BLUE ARROW CAPITAL MANAGEMENT LLC
13F
Company
0.27%
160,000
$1,488,000 31 Mar 2015
13F
TFS CAPITAL LLC
13F
Company
0.22%
132,314
$1,231,000 31 Mar 2015
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.22%
128,249
$1,193,000 31 Mar 2015
13F
SABBY MANAGEMENT, LLC
13F
Company
0.19%
113,165
$1,052,000 31 Mar 2015
13F
QS Investors, LLC
13F
Company
0.19%
110,486
$1,027,000 31 Mar 2015
13F
BlackRock Investment Management, LLC
13F
Company
0.18%
103,719
$965,000 31 Mar 2015
13F
CREDIT AGRICOLE S A
13F
Individual
0.17%
100,784
$937,000 31 Mar 2015
13F
SG Americas Securities, LLC
13F
Company
0.17%
99,604
$926,000 31 Mar 2015
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.12%
73,700
$879,000 31 Mar 2015
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.15%
89,640
$834,000 31 Mar 2015
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.15%
86,041
$800,000 31 Mar 2015
13F
CREDIT SUISSE AG/
13F
Company
0.14%
82,797
$771,000 31 Mar 2015
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.14%
80,383
$748,000 31 Mar 2015
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
79,300
$737,000 31 Mar 2015
13F
Trexquant Investment LP
13F
Company
0.13%
78,400
$729,000 31 Mar 2015
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.13%
74,553
$694,000 31 Mar 2015
13F
JW Asset Management, LLC
13F
Company
0.12%
70,080
$652,000 31 Mar 2015
13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2015

As of 30 Jun 2015, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,413,548 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, PAULSON & CO. INC., Palo Alto Investors, LLC, GOLDMAN SACHS GROUP INC, STATE STREET CORP, KINGDON CAPITAL MANAGEMENT, L.L.C., BlackRock Fund Advisors, MORGAN STANLEY, venBio Select Advisor LLC, and GREAT POINT PARTNERS LLC. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders
108
Q2 2015 holders
109
Holder diff
1
Investor Q1 2015 Shares Q2 2015 Shares Share Diff Share Chg % Q1 2015 Value $ Q2 2015 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.